Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

A Randomized Phase III Trial on the Role of Esophagectomy in Complete Responders to Preoperative Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESOPRESSO).

Park SR, Yoon DH, Kim JH, Kim YH, Kim HR, Lee HJ, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Lee JH, Ahn JY, Ryu JS, Cho KJ, Kim SB.

Anticancer Res. 2019 Sep;39(9):5123-5133. doi: 10.21873/anticanres.13707.

PMID:
31519624
2.

CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596).

Tang H, Tan L, Shen Y, Wang H, Lin M, Feng M, Xu S, Guo W, Qian C, Liu T, Zeng Z, Hou Y, Yu Z, Jiang H, Li Z, Chen C, Lian C, Du M, Li H, Xie D, Yin J, Zhao N, Wang Q.

BMC Cancer. 2017 Jun 28;17(1):450. doi: 10.1186/s12885-017-3446-7.

3.

Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.

Hashimoto J, Kato K, Ito Y, Kojima T, Akimoto T, Daiko H, Hamamoto Y, Matsushita H, Katano S, Hara H, Tanaka Y, Saito Y, Nagashima K, Igaki H.

Int J Clin Oncol. 2019 Jan;24(1):60-67. doi: 10.1007/s10147-018-1336-x. Epub 2018 Aug 14.

PMID:
30109544
4.

Is There a Correlation Between Clinical Complete Response and Pathological Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer?

Liu SL, Xi M, Yang H, Yang YD, Wu YJ, Zhao L, Zhang P, Luo LL, Liu MZ.

Ann Surg Oncol. 2016 Jan;23(1):273-81. doi: 10.1245/s10434-015-4764-0. Epub 2015 Jul 28.

PMID:
26215200
5.

Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.

Naik KB, Liu Y, Goodman M, Gillespie TW, Pickens A, Force SD, Steuer CE, Owonikoko TK, Ramalingam SS, Higgins K, Beitler JJ, Shin DM, Willingham FF, El-Rayes B, Landry JC, Fernandez FG, Saba NF.

Cancer. 2017 Sep 15;123(18):3476-3485. doi: 10.1002/cncr.30763. Epub 2017 May 2.

6.

Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone.

Chen Y, Lu Y, Wang Y, Yang H, Xia Y, Chen M, Song H, Li T, Li D, Wang J, Li S, Wang J.

Dis Esophagus. 2014 Feb-Mar;27(2):134-40. doi: 10.1111/j.1442-2050.2012.01440.x. Epub 2012 Oct 22.

PMID:
23088212
7.

Randomized phase 2 trial of S1 and oxaliplatin-based chemoradiotherapy with or without induction chemotherapy for esophageal cancer.

Yoon DH, Jang G, Kim JH, Kim YH, Kim JY, Kim HR, Jung HY, Lee GH, Song HY, Cho KJ, Ryu JS, Kim SB.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):489-96. doi: 10.1016/j.ijrobp.2014.11.019. Epub 2015 Jan 30.

PMID:
25680595
8.

Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer.

Vellayappan BA, Soon YY, Ku GY, Leong CN, Lu JJ, Tey JC.

Cochrane Database Syst Rev. 2017 Aug 22;8:CD010511. doi: 10.1002/14651858.CD010511.pub2. Review.

9.

Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery.

Hamai Y, Hihara J, Emi M, Furukawa T, Murakami Y, Nishibuchi I, Ibuki Y, Yamakita I, Kurokawa T, Nagata Y, Okada M.

World J Surg. 2018 May;42(5):1496-1505. doi: 10.1007/s00268-017-4283-1.

PMID:
29030675
10.

Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stageĀ II/III esophageal squamous cell carcinoma patients.

Fujiwara Y, Yoshikawa R, Kamikonya N, Nakayama T, Kitani K, Tsujie M, Yukawa M, Inoue M, Yamamura T.

Oncol Rep. 2012 Aug;28(2):446-52. doi: 10.3892/or.2012.1847. Epub 2012 Jun 1.

11.

Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.

Koo DH, Park SI, Kim YH, Kim JH, Jung HY, Lee GH, Choi KD, Song HJ, Song HY, Shin JH, Cho KJ, Yoon DH, Kim SB.

Cancer Chemother Pharmacol. 2012 Mar;69(3):655-63. doi: 10.1007/s00280-011-1750-5. Epub 2011 Oct 4.

PMID:
21968953
12.
13.

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma.

Lee JL, Park SI, Kim SB, Jung HY, Lee GH, Kim JH, Song HY, Cho KJ, Kim WK, Lee JS, Kim SH, Min YI.

Ann Oncol. 2004 Jun;15(6):947-54.

PMID:
15151953
14.

A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma.

Yamashita H, Nakagawa K, Yamada K, Kaminishi M, Mafune K, Ohtomo K.

Dis Esophagus. 2008;21(5):430-6. doi: 10.1111/j.1442-2050.2007.00793.x.

PMID:
19125797
15.

[A multi-centered randomized controlled study of neo-adjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of esophagus: an interim analysis].

YANG H, FU JH, LIU MZ, FANG WT, WANG JM, CHEN YP, CHEN ZJ, XIANG JQ, YANG HJ, MAO WM, ZHENG X, ZHU CC, KONG M, HAN YT, LI T.

Zhonghua Yi Xue Za Zhi. 2012 Apr 17;92(15):1028-32. Chinese.

PMID:
22781642
16.

Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.

Hsu FM, Lee JM, Huang PM, Lin CC, Hsu CH, Tsai YC, Lee YC, Chia-Hsien Cheng J.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e593-9. doi: 10.1016/j.ijrobp.2011.04.032. Epub 2011 Jun 12.

PMID:
21658851
17.

Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.

Chen Y, Hao D, Wu X, Xing W, Yang Y, He C, Wang W, Liu J, Wang J.

Dis Esophagus. 2017 Jul 1;30(7):1-7. doi: 10.1093/dote/dox016.

PMID:
28475725
18.

Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.

Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB Jr, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1484-93.

PMID:
15590179
19.

Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery.

Tu CC, Hsu PK, Chien LI, Liu WC, Huang CS, Hsieh CC, Hsu HS, Wu YC.

BMC Cancer. 2017 Jan 19;17(1):62. doi: 10.1186/s12885-017-3063-5.

20.

Clinical complete response after chemoradiotherapy for carcinoma of thoracic esophagus: Is esophagectomy always necessary? A systematic review and meta-analysis.

Wang J, Qin J, Jing S, Liu Q, Cheng Y, Wang Y, Cao F.

Thorac Cancer. 2018 Dec;9(12):1638-1647. doi: 10.1111/1759-7714.12874. Epub 2018 Oct 1.

Supplemental Content

Support Center